UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 814-01211 Great Elm Capital Corp. (Exact name of registrant as specified in its charter) Maryland 81-2621577 (State or other jurisdiction of incorporation or organizat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) Delaware 72-0487776 842 West Sam Houston Parkway North, Suite 400 Houston, Texas 77024 (Address of principal executive ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-37635 AXSOME THERAPEUTICS, INC. (State or other jurisdiction of incorporation or organization) (I.R.S. ...

Intrepid Announces First Quarter 2025 Results Denver, CO, May 5, 2025 - Intrepid Potash, Inc. ("Intrepid", "the Company", "we", "us", or "our") (NYSE:IPI) today reported its results for the first quarter of 2025. First Quarter Highlights & Management Commentary Improving potash and Trio unit economics, strong Trio pricing, and our highest quarterly sales volumes since 2016 led to strong first quarter 2025 results, highlighted by: ® ® Kevin Crutchfield, Intrepid's Chief Executive Officer, commented: "Since j ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________________ FORM 10-Q Commission File Number: 001-38678 ________________________________________________ UPWORK INC. (Exact Name of Registrant as Specified in its Charter) ________________________________________________ Delaware 46-4337682 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 530 Lytton Avenue, Suite 301 Palo Alto, California 94301 (Addres ...

Tidewater Inc. 842 West Sam Houston Parkway North, Suite 400 Houston, TX 77024, USA +1.713.470.5300 Tidewater Reports Results for the Three Months Ended March 31, 2025 First Quarter 2025 Highlights Share Count Reduction and 2025 Guidance HOUSTON, May 5, 2025 - Tidewater Inc. (NYSE:TDW) announced today revenue for the three months ended March 31, 2025 of $333.4 million, compared with $321.2 million for the three months ended March 31, 2024. Tidewater's net income for the three months ended March 31, 2025, wa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-07151 THE CLOROX COMPANY (Exact name of registrant as specified in its charter) Delaware 31-0595760 (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ [Mark One] þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-39541 WHEELS UP EXPERIENCE INC. (Exact Name of Registrant as Specif ...

(Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025. OR ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________. Commission File No. 0-16469 INTERPARFUMS, INC. (State or other jurisdiction of ...

Financial Performance - Net revenues for Q1 2025 were $776.0 million, a decrease of $183.1 million, or 19.1%, compared to $959.1 million in Q1 2024, primarily due to the divestiture of the Towanda facility and a 15% decline in Core Revenue[5][10] - The net loss for Q1 2025 was $179.8 million, compared to a net loss of $27.7 million in the same period last year, an increase of $152.1 million, largely due to a $125 million non-cash goodwill impairment charge[6][10] - Adjusted EBITDA for Q1 2025 was $21.9 million, a decline of $46.8 million from $68.7 million in Q1 2024, with an Adjusted EBITDA Margin of 2.8%, down 440 basis points year-over-year[8][10] - Adjusted EPS for Q1 2025 was ($0.17), compared to $0.21 in Q1 2024, reflecting the impact of the non-cash goodwill impairment charge[7][10] - The operating loss margin for Q1 2025 was (22.1%), compared to (2.9%) for the same quarter last year[10] - Gross margin declined by 35.1% to $112.1 million, down from $172.6 million year-over-year[31] - Operating loss increased significantly to $171.8 million, compared to a loss of $28.3 million in the prior year, representing a 507.5% increase[31] - Net loss for the quarter was $179.8 million, a 548.4% increase from a loss of $27.7 million in the same quarter last year[31] - Adjusted net loss income was $(14.2) million for Q1 2025, a significant decline from adjusted net income of $18.4 million in Q1 2024[39] - The company reported a diluted net loss per share of $2.12, compared to $0.32 in the same quarter last year[31] Cash Flow and Working Capital - Net cash used in operating activities increased to $83.5 million in Q1 2025, up from $11.0 million in Q1 2024, primarily due to unfavorable earnings changes and a decrease in working capital[11] - Free cash flow for Q1 2025 was $(125.4) million, compared to $(45.7) million in Q1 2024[44] - Accounts receivable increased to $453.6 million from $388.4 million, indicating a rise in outstanding customer payments[33] Segment Performance - North America segment net revenue was $530.6 million, a decline of $149.4 million, or 22.0%, driven by a 17% decrease in Core Revenue due to weaker market demand[17] - Europe segment net revenue was $245.4 million, a decline of $33.7 million, or 12.1%, primarily due to a 9% decrease in Core Revenue from market softness[17] - North America revenues fell by 22.0% to $530.6 million, while Europe revenues decreased by 12.1% to $245.4 million[46] Asset and Liability Changes - Total assets decreased to $2,429.3 million from $2,620.2 million at the end of the previous year[33] - Cash and cash equivalents decreased to $132.5 million from $150.3 million at the end of the previous year[33] - Net debt increased to $1,049.7 million as of March 29, 2025, compared to $1,033.1 million at the end of 2024[44] - The net debt leverage ratio rose to 4.6x, up from 3.8x in the previous quarter[44] Impairment and Charges - Goodwill impairment charge of $124.6 million was recorded, reflecting significant asset valuation adjustments[31] - The company incurred a goodwill impairment of $124.6 million in Q1 2025, which was not present in Q1 2024[39] - The company recorded $11.9 million in net legal and professional expenses and settlements during Q1 2025[41] Strategic Focus - The company remains committed to its transformation strategy, focusing on cost reduction and improving quality and service levels despite challenging market conditions[4]